228
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® System

&
Pages 180-183 | Received 16 Jun 2011, Accepted 21 Nov 2011, Published online: 17 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Domenico Capone, Mauro Cataldi, Bruna Guida, Teresa Mosca & Giovanni Tarantino. (2018) Comparison of the everolimus concentrations measured in whole blood with everolimus QMS or sirolimus CMIA. Scandinavian Journal of Clinical and Laboratory Investigation 78:4, pages 275-280.
Read now

Articles from other publishers (4)

Cristiano Ialongo, Maria Sapio & Antonio Angeloni. (2023) Analytical Performance of the New Siemens Affinity Chrome-Mediated Immunoassay Everolimus Assay and Its Interchangeability With the Thermo Quantitative Microsphere System for Routine Therapeutic Drug Monitoring of Patients After Solid Organ Transplantation. Therapeutic Drug Monitoring 45:2, pages 217-222.
Crossref
Maria Shipkova, Dennis A. Hesselink, David W. Holt, Eliane M. Billaud, Teun van Gelder, Paweł K. Kunicki, Mercè Brunet, Klemens Budde, Markus J. Barten, Paolo De Simone, Eberhard Wieland, Olga Millán López, Satohiro Masuda, Christoph Seger, Nicolas Picard, Michael Oellerich, Loralie J. Langman, Pierre Wallemacq, Raymond G. Morris, Carol Thompson & Pierre Marquet. (2016) Therapeutic Drug Monitoring of Everolimus. Therapeutic Drug Monitoring 38:2, pages 143-169.
Crossref
Amitava Dasgupta. 2016. Personalized Immunosuppression in Transplantation. Personalized Immunosuppression in Transplantation 29 56 .
Irene Shu, Angela M. Wright, Wayne L. Chandler, David W. Bernard & Ping Wang. (2014) Analytical Performance of QMS Everolimus Assay on Ortho Vitros 5,1 FS Fusion Analyzer. Therapeutic Drug Monitoring 36:2, pages 264-268.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.